A phase IIa clinical trial of EOS-448
Latest Information Update: 21 May 2021
At a glance
- Drugs Belrestotug (Primary)
- Indications Head and neck cancer; Malignant melanoma; Multiple myeloma; Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 21 May 2021 New trial record